A glutathione transferase from Agrobacterium tumefaciens reveals a novel class of bacterial GST superfamily
Antioxidants (Basel, Switzerland), 10(9), 1352
10.12938/bmfh.2022-078 78 MohammadiS.MemarianA.SedighiS.BehnampourN.YazdaniY
Incidence of New Fractures in Patients Treated with Kyphoplasty/Vertebroplasty or Conservative Methods Alper Tabanli, Hakan Yilmaz, Hseyin Berk Benek, Mehmet Akif Ercan, Gulsen Ozgenc, Cafer Ak, Onur Bologur, Emrah Akcay, Alaettin Yurt Medicina .2025
10.3390/ijms15023319 Int
Lillys Orfoglipron in the ATTAIN-MAINTAIN trial showed that following its SURMOUNT-5 trial (72-week treatment with either Semaglutide at 2.4mg, or Tirzepatide at 15mg) a 52-week maintenance dosing of Orfoglipron (24/36mg) was offered